Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
100th anniversary
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Author's Takes
Reviews
Reviews
View all reviews ...
Review Series
Substance Use Disorders (Upcoming)
Sex Differences in Medicine (Upcoming)
Vascular Malformations (Apr 2024)
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
Korsmeyer Award 25th Anniversary Collection (Jan 2023)
Aging (Jul 2022)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Medicine
Research Letters
Letters to the Editor
Editorials
Commentaries
Reviews
Viewpoints
Top read articles
Clinical Medicine
Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variant
Douglas E. Vaughan
Douglas E. Vaughan
Published September 15, 2023
Citation Information:
J Clin Invest.
2023;
133(18)
:e173932.
https://doi.org/10.1172/JCI173932
.
View:
Text
|
PDF
Editor's note
Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variant
Text
PDF
Abstract
Authors
Douglas E. Vaughan
×
Full Text PDF |
Download
(44.90 KB)